Literature DB >> 8897928

Alpha 1-adrenergic stimulation induces cardiac tolerance to hypoxia via induction and activation of Mn-SOD.

N Yamashita1, M Nishida, S Hoshida, J Igarashi, M Hori, T Kuzuya, M Tada.   

Abstract

We examined whether or not alpha 1-adrenergic stimulation increases the tolerance of the heart to ischemia using a hypoxia-reoxygenation model of cardiac myocytes. After exposure to norepinephrine (NE; 0.2 microM) for 24 h, the manganese superoxide dismutase (Mn-SOD) content and activity in the cells were increased from 0.61 +/- 0.03 to 0.87 +/- 0.04 microgram/dish and 22 +/- 1 to 55 +/- 4 U/dish, respectively. The specific activity of Mn-SOD was also increased from 36 to 63 U/microgram Mn-SOD protein after the stimulation with NE. Prazosin (2 microM) abolished the increase in Mn-SOD activity (U/mg total protein). Creatine kinase (CK) release after hypoxia (PO2 7 mmHg; 3 h)-reoxygenation (1 h) from cells pretreated with NE in the presence of propranolol and yohimbine for 24 h was attenuated by 48% compared with that from cells without NE stimulation. When antisense oligodeoxyribonucleotides to Mn-SOD were added to myocyte cultures, the increase in Mn-SOD activity (U/mg total protein) and the attenuation of CK release after the addition of NE in the presence of propranolol and yohimbine were not observed. These results suggest that alpha 1-adrenergic stimulation increases the tolerance of myocytes to hypoxia through induction and activation of Mn-SOD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897928     DOI: 10.1152/ajpheart.1996.271.4.H1356

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.

Authors:  Brian C Jensen; Timothy D O'Connell; Paul C Simpson
Journal:  J Mol Cell Cardiol       Date:  2010-11-28       Impact factor: 5.000

2.  Is the use of catecholamine before ischemic arrest safe? Effect of catecholamine on rat heart ischemia/reperfusion injury.

Authors:  Y Shimada; F Yamamoto; H Yamamoto; R Newling
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-07

3.  The involvement of cytokines in the second window of ischaemic preconditioning.

Authors:  N Yamashita; S Hoshida; K Otsu; N Taniguchi; T Kuzuya; M Hori
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

4.  Monophosphoryl lipid A provides biphasic cardioprotection against ischaemia-reperfusion injury in rat hearts.

Authors:  N Yamashita; S Hoshida; K Otsu; N Taniguchi; T Kuzuya; M Hori
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 5.  Alpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation.

Authors:  Brian C Jensen; Timothy D OʼConnell; Paul C Simpson
Journal:  J Cardiovasc Pharmacol       Date:  2014-04       Impact factor: 3.105

6.  α1A-Adrenergic receptor prevents cardiac ischemic damage through PKCδ/GLUT1/4-mediated glucose uptake.

Authors:  Ting Shi; Robert S Papay; Dianne M Perez
Journal:  J Recept Signal Transduct Res       Date:  2015-09-29       Impact factor: 2.092

7.  Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation.

Authors:  N Yamashita; S Hoshida; K Otsu; M Asahi; T Kuzuya; M Hori
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.